Automation Upgrade at Influenza Vaccine Manufacturing Facility

This £20m retrofit and phased expansion of an existing biotechnology facility aimed to reduce costs by increasing efficiency, increasing yield, reducing waste, and increasing process automation – including multiple interfaces with manufacturing.



  • Liverpool, North West England, UK


  • MedImmune

Project Status

  • Complete


  • ISPE 2013 Facility of the Year Award for Equipment Innovation


  • 'Facility of the Year' Award from the IPSE
Increase in yield
15% 15%
Reduction in seasonal labour
25% 25%
Decrease in reject rate
8% 8%